ARCHIVES

Cancer researchers support “responsible” human stem cell research.

This article is from The Cancer Letter archive.

Vol. 31 No. 29 | July 22, 2005

Download PDF Visit The Full Archive

Related Articles

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

NCI Clarifies IRPG Application Receipt, Funding Policies

September 3, 1993

NIH Challenge Grant Announcement

March 6, 2009

No Justification Provided: DePinho’s Nixing of Tenure Renewals May Bring Censure to MD Anderson

April 25, 2014

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

Tracor Lands Second Biggest NCI Contract-$6.6 Million To Manage Commercial Labs’ Portion Of Bioassay Program

April 19, 1974